Developer docs
API playgroundTry for free, no card

Search company profiles

OsteoSys

Full company profile

uuid002al8q

Namestring
OsteoSys
Legal namestring
OSTEOSYS Corp. (주식회사 오스테오시스)
Websiteurl
osteosys.com
Company typeenum
Public
Founded yearint
2000
Descriptiontext

Headquartered in Seoul, South Korea, OsteoSys is a publicly listed medical device manufacturer specializing in bone densitometry, body composition analysis, and musculoskeletal therapy equipment. The company develops, manufactures, and sells DXA (Dual-energy X-ray Absorptiometry) systems for clinical osteoporosis and sarcopenia diagnosis, quantitative ultrasound (QUS) devices for portable bone density screening, extracorporeal shock wave therapy (ESWT) systems for musculoskeletal pain, and a dedicated preclinical DXA cabinet (iNSiGHT) for laboratory animal research. OsteoSys commands approximately 80% domestic market share in Korea's bone density DXA segment and exports its products to over 70 countries via a network of 150+ distributors, with documented installations at Harvard Joslin Diabetes Center, the US National Institutes of Health, MD Anderson Cancer Center, Mayo Clinic, Mount Sinai Hospital, the University of Tokyo, and New York University. The company was the first Korean bone densitometer manufacturer to receive EU Medical Device Regulation (MDR 2017/745) certification for its full DXA portfolio, and its Primus whole-body scanner has been recognized by the Korean Ministry of Health and Welfare as a new medical technology for sarcopenia diagnosis since 2019.

OsteoSys's product architecture centers on three technology platforms: (1) DXA-based whole-body, half-body, table, and peripheral scanners (PRIMUS, EXCELLUS, DEXXUM T, DEXXUM T QUANTUM, EXA-3000, EXA-PRESTO) for bone mineral density and body composition measurement; (2) QUS-based portable and stand-alone devices (SONOST 2000, SONOST 3000, BeeTLe) using SOS and BUA measurements at the calcaneus, with the BeeTLe offering wireless NFC/Bluetooth mobile control and a 5-second scan; and (3) the NPT-Sonicure ESWT device employing digital array control with 3D dynamic focusing for pain-free musculoskeletal treatment. The iNSiGHT preclinical platform combines cone beam HFG and flat panel detector technology to deliver 25-second in-vivo body composition scans at 100 micrometer resolution, eliminating the need for animal sacrifice in longitudinal studies. Software integrations include the Medimaps TBS iNsight trabecular bone score module, which adds AI-powered bone microarchitecture analysis to the Primus system.

The company generates revenue through three primary streams: one-time sales of medical device hardware (bone densitometers and ESWT systems) to healthcare providers, hospitals, and research institutions; recurring or licensed software solutions including body composition analysis and TBS iNsight integrations; and ongoing service and maintenance contracts with both domestic (Korea hotline 1551-5099) and international customer support. Distribution combines direct enterprise sales for large Korean and Chinese institutional accounts with an extensive international channel partner network, supplemented by direct public-sector tender wins such as the consecutive Turkish Ministry of Health contracts. Pricing is quote-based and not publicly disclosed, consistent with the enterprise medical device sales model. OsteoSys maintains offices in Seoul (headquarters) and Shanghai (China regional), is led by founder and CEO Young-bok Ahn, and is publicly listed on the Korea Stock Exchange (KOSPI).

Short descriptiontext

OsteoSys is a publicly listed Seoul-based medical device manufacturer producing DXA bone densitometers, QUS ultrasound scanners, ESWT pain therapy systems, and preclinical DXA cabinets for osteoporosis, sarcopenia, body composition, and musculoskeletal applications, serving hospitals, research institutions, and veterinary labs across 70+ countries with approximately 80% domestic Korean market share.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
11–50
akta.pro rankint
HeadquartersSeoul, South Korea
HQ citystring
Seoul
HQ countrystring
South Korea
HQ regionstring
Asia
Markets served

Serves global market

Offices2 records

Each record includes

City, Country, Type, Description, Source

Keyword5 values
bone densitometry equipment, DXA body composition, quantitative ultrasound BMD, shock wave therapy devices, preclinical DXA imaging
Industry2 codes
PRIMARYHLAHABAA
X-ray & Fluoroscopy Systems
Healthcare & Life Sciences/Medical Devices & Diagnostics/Medical Imaging & Radiology Equipment
SECONDARYHLAKALAM
Pain Management (Spine & Musculoskeletal)
NAICS code1 code
  • Electromedical and Electrotherapeutic Apparatus Manufacturing334510
SIC code1 code
  • Electromedical & Electrotherapeutic Apparatus3845
Product category
Bone Densitometry and Musculoskeletal Medical Imaging Devices
GTM motion2 records

Each record includes

Type, Description, Source

Revenue model3 records
1Medical Device Sales
TypeOne Time License
Description

Sale of bone mineral density diagnostic equipment (DXA systems, QUS devices) and ESWT treatment devices to healthcare providers, hospitals, and research institutions.

osteosys.com
2Software Solutions
TypeSubscription Recurring
Description

Sale of related software solutions including body composition analysis software, BMD reporting systems, and TBS iNsight integration for enhanced bone health assessment.

osteosys.com
3Service and Maintenance
TypeProfessional Services
Description

Customer service and support including remote support services, domestic service hotline (1551-5099), and overseas service support.

osteosys.com
Marketing channels4 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels3 records

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components5 values
Personnel, Technology or R&D, Operations, Marketing or Sales, Supply Chain
Pricing details1 tier
1Enterprise/Institutional Pricing
ModelOtherBilling cadenceMulti-year contract
Notes

Medical device pricing requires direct inquiry. OsteoSys provides sales contact for international (info@osteosys.com) and domestic Korean customers (domestic@osteosys.com).

osteosys.com
GTM typeB2B
B2B
Offering typeHardware or Manufacturing
Hardware or Manufacturing
Brand1 record
1SoniCure
Description

Brand name for OsteoSys's Extracorporeal Shock Wave Therapy (ESWT) technology products.

Core offering1 text field

OsteoSys manufactures and sells bone mineral density (BMD) diagnostic systems based on Dual Energy X-ray Absorptiometry (DXA) and Quantitative Ultrasound (QUS), body composition analyzers, Extracorporeal Shock Wave Therapy (ESWT) devices for musculoskeletal pain, and preclinical/veterinary DXA imaging cabinets. Its products serve hospitals, clinics, research institutions, universities and government health programs for osteoporosis diagnosis, sarcopenia assessment, body composition analysis and musculoskeletal pain therapy.

Differentiator
Functional benefit
Problem solved
Quantifiable outcome1 of 4 values shown
  • 80% domestic market share in Korea's bone density DXA device market
+3 more records
Product overview1 text field

OsteoSys is a medical device manufacturer specializing in bone health diagnostic equipment and musculoskeletal therapy devices. The product portfolio includes: BMD diagnostic systems using DXA technology (PRIMUS whole-body scanner, EXCELLUS half-body scanner, DEXXUM T series, EXA series) and QUS technology (SONOST series, BeeTLe portable device); NPT-Sonicure for extracorporeal shock wave therapy treating musculoskeletal pain conditions; and iNSiGHT for preclinical/veterinary DXA analysis of lab animals. The company holds approximately 80% domestic Korean market share and exports to over 70 countries worldwide.

Product and service11 records
1PRIMUS
CategoryWhole-body DXA bone densitometry
Description

Whole-body DXA scanner for bone mineral density and body composition analysis including lean mass, fat mass and bone mass measurements; recognized as new medical technology since 2019 for simultaneous sarcopenia and osteoporosis diagnosis.

2EXCELLUS
CategoryHalf-body DXA body composition
Description

Half-body DXA scanner for precise measurement of fat mass, muscle mass and bone mineral density with scientific body composition monitoring.

3DEXXUM T
CategoryTable DXA bone densitometry
Description

Table DXA system for bone mineral density assessment at the spine and hip; EU MDR certified.

4DEXXUM T QUANTUM
CategoryTable DXA bone densitometry
Description

Advanced table DXA system with quantum technology for enhanced bone density measurements; EU MDR certified.

5EXA-3000
CategoryPeripheral DXA bone densitometry
Description

Peripheral DXA system for bone mineral density measurement at specific skeletal sites such as the forearm or heel; EU MDR certified.

6EXA-PRESTO
CategoryPeripheral DXA bone densitometry
Description

Peripheral DXA device for clinical bone density assessment in office or point-of-care settings.

7SONOST 3000
CategoryQuantitative ultrasound bone densitometry
Description

Portable stand-alone quantitative ultrasound (QUS) bone densitometer with embedded PC, colorful touch screen, built-in thermal printer, temperature compensation and automatic probe positioning; uses SOS and BUA measurements for calcaneal BMD calculation.

8SONOST-2000
CategoryQuantitative ultrasound bone densitometry
Description

Quantitative ultrasound bone densitometer for calcaneal bone mineral density measurement.

9BeeTLe
CategoryPortable QUS bone densitometry
Description

Portable wireless QUS bone mineral densitometer with NFC and Bluetooth functions, providing a 5-second calcaneal BMD test controlled via a mobile phone application through one-touch measurement.

10NPT-Sonicure (SoniCure)
CategoryExtracorporeal shock wave therapy
Description

Next-generation extracorporeal shock wave therapy (ESWT) device based on digital array control technology with world-first 3D dynamic focusing; provides software-based depth adjustment without gel pad replacement for pain-free musculoskeletal treatment at the skin surface.

11iNSiGHT
CategoryPreclinical DXA imaging
Description

Fully shielded preclinical DXA cabinet for in-vivo body composition and BMD analysis in lab animals; uses cone beam HFG and a flat panel detector to complete scans in 25 seconds (10 seconds of X-ray exposure) with 100-micron high-resolution imaging, multiple ROIs and longitudinal study capability without requiring animal sacrifice.

Scale indicator6 records

Each record includes

Type, Value, Description, Source

Partnership1 partner
Strategic tierCoreTypeTechnology or IntegrationAnnounced on2022-11-14
Description

Medimaps Group, a Swiss/Global med-tech company specializing in image processing software for bone health, partnered with OsteoSys to integrate TBS iNsight (Trabecular Bone Score) technology into OsteoSys' Primus Whole Body DXA scanner. This partnership enhances osteoporosis fracture risk assessment by combining BMD measurement with bone microarchitecture analysis using AI-powered technology. TBS iNsight has CE 2797 mark, FDA 510(k) clearance, and is cleared in 60+ countries. The integration expands access to Medimaps' technology throughout Southeast Asia, Europe, and South America.

Recent move9 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight5 records

Each record includes

Type, Description

Peers10 records
TypeDirect peer
Description

Hologic is the global market leader in DXA bone densitometry (Discovery/Horizon platforms) alongside women's health imaging. It is OsteoSys's most direct competitor in whole-body DXA sales to hospitals and clinics worldwide.

TypeBroad incumbent
Description

Hitachi supplies diagnostic imaging systems including X-ray modalities used in hospitals globally. As a broad incumbent with overlapping imaging channels, it competes with OsteoSys at the hospital capital-equipment procurement level, especially in Asia.

TypeEmerging player
Description

BeamMed (Israel) develops quantitative ultrasound (QUS) bone densitometry devices (Sunlight Omnisense). It overlaps directly with OsteoSys's SONOST and BeeTLe QUS product lines in pediatric and point-of-care bone assessment.

TypeOthers
Description

Medimaps Group (Switzerland) provides TBS iNsight, a CE-marked and FDA-cleared trabecular bone score software that OsteoSys integrates into PRIMUS. It is a strategic partner and adjacent ecosystem peer rather than a direct device competitor.

TypeDirect peer
Description

DMS Group (France) is a specialist DXA and bone densitometry manufacturer (Stratos, Lexxos) competing head-to-head with OsteoSys's PRIMUS, EXCELLUS and DEXXUM T lines in European and emerging-market tenders.

TypeRegional player
Description

Furuno (Japan) supplies medical imaging and electronic equipment, including diagnostic modalities in the Japanese market. It is a regional peer for OsteoSys's preclinical DXA and bone densitometry exports to Japan (e.g., University of Tokyo).

TypeBroad incumbent
Description

GE Healthcare sells the Lunar iDXA bone densitometer line as part of a much broader diagnostic imaging portfolio. OsteoSys explicitly positions itself as a top-3 global bone densitometry player 'alongside GE and Hologic,' making GE the anchor incumbent peer.

8Norland (CooperSurgical)
TypeDirect peer
Description

Norland at CooperSurgical is a legacy DXA bone densitometer brand (XR-Series) with overlapping research and clinical customers. It is a direct substitute for OsteoSys's table DXA systems in osteoporosis and body composition research labs.

9Swissray
TypeBroad incumbent
Description

Swissray manufactures digital radiography (DR) X-ray systems used in hospitals and clinics. Its DR X-ray capability overlaps with the X-ray based technology stack underlying OsteoSys's DXA and combined DR X-ray/DXA veterinary platform.

TypeBroad incumbent
Description

Philips Healthcare is a global diagnostic imaging incumbent whose X-ray and women's-health portfolio overlaps with OsteoSys's DXA positioning at large hospital networks and reference centers.

Market position
Strengths5 records

Each record includes

Headline, Details, Source

Weaknesses5 records

Each record includes

Headline, Details, Source

Competitive moat5 records

Each record includes

Type, Details

Key risks5 records

Each record includes

Headline, Details, Source

Key highlights7 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Named customers8 records

Each record includes

Name, Industry, Type, Use case, Source, UUID

Segment3 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile4 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
Yes
API detail
Has APIbool
No

Docs URL, Description

Integration1 record

Each record includes

Title, Type, Description, Source

AI maturity
App detail

Has app

Feature5 records

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles1 record

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

No data
Compliance1 record

Each record includes

Name, Class, Description

Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

OsteoSys

Bone Densitometry and Musculoskeletal Medical Imaging Devicesosteosys.com

OsteoSys is a publicly listed Seoul-based medical device manufacturer producing DXA bone densitometers, QUS ultrasound scanners, ESWT pain therapy systems, and preclinical DXA cabinets for osteoporosis, sarcopenia, body composition, and musculoskeletal applications, serving hospitals, research institutions, and veterinary labs across 70+ countries with approximately 80% domestic Korean market share.

What OsteoSys does

Headquartered in Seoul, South Korea, OsteoSys is a publicly listed medical device manufacturer specializing in bone densitometry, body composition analysis, and musculoskeletal therapy equipment. The company develops, manufactures, and sells DXA (Dual-energy X-ray Absorptiometry) systems for clinical osteoporosis and sarcopenia diagnosis, quantitative ultrasound (QUS) devices for portable bone density screening, extracorporeal shock wave therapy (ESWT) systems for musculoskeletal pain, and a dedicated preclinical DXA cabinet (iNSiGHT) for laboratory animal research. OsteoSys commands approximately 80% domestic market share in Korea's bone density DXA segment and exports its products to over 70 countries via a network of 150+ distributors, with documented installations at Harvard Joslin Diabetes Center, the US National Institutes of Health, MD Anderson Cancer Center, Mayo Clinic, Mount Sinai Hospital, the University of Tokyo, and New York University. The company was the first Korean bone densitometer manufacturer to receive EU Medical Device Regulation (MDR 2017/745) certification for its full DXA portfolio, and its Primus whole-body scanner has been recognized by the Korean Ministry of Health and Welfare as a new medical technology for sarcopenia diagnosis since 2019.

OsteoSys's product architecture centers on three technology platforms: (1) DXA-based whole-body, half-body, table, and peripheral scanners (PRIMUS, EXCELLUS, DEXXUM T, DEXXUM T QUANTUM, EXA-3000, EXA-PRESTO) for bone mineral density and body composition measurement; (2) QUS-based portable and stand-alone devices (SONOST 2000, SONOST 3000, BeeTLe) using SOS and BUA measurements at the calcaneus, with the BeeTLe offering wireless NFC/Bluetooth mobile control and a 5-second scan; and (3) the NPT-Sonicure ESWT device employing digital array control with 3D dynamic focusing for pain-free musculoskeletal treatment. The iNSiGHT preclinical platform combines cone beam HFG and flat panel detector technology to deliver 25-second in-vivo body composition scans at 100 micrometer resolution, eliminating the need for animal sacrifice in longitudinal studies. Software integrations include the Medimaps TBS iNsight trabecular bone score module, which adds AI-powered bone microarchitecture analysis to the Primus system.

The company generates revenue through three primary streams: one-time sales of medical device hardware (bone densitometers and ESWT systems) to healthcare providers, hospitals, and research institutions; recurring or licensed software solutions including body composition analysis and TBS iNsight integrations; and ongoing service and maintenance contracts with both domestic (Korea hotline 1551-5099) and international customer support. Distribution combines direct enterprise sales for large Korean and Chinese institutional accounts with an extensive international channel partner network, supplemented by direct public-sector tender wins such as the consecutive Turkish Ministry of Health contracts. Pricing is quote-based and not publicly disclosed, consistent with the enterprise medical device sales model. OsteoSys maintains offices in Seoul (headquarters) and Shanghai (China regional), is led by founder and CEO Young-bok Ahn, and is publicly listed on the Korea Stock Exchange (KOSPI).

OsteoSys firmographics

Firmographics
Name
OsteoSys
Legal name
OSTEOSYS Corp. (주식회사 오스테오시스)
Website
https://osteosys.com
Company type
Public
Founded year
2000
Operating status
Operating
Headcount range
11–50 employees
Short description
OsteoSys is a publicly listed Seoul-based medical device manufacturer producing DXA bone densitometers, QUS ultrasound scanners, ESWT pain therapy systems, and preclinical DXA cabinets for osteoporosis, sarcopenia, body composition, and musculoskeletal applications, serving hospitals, research institutions, and veterinary labs across 70+ countries with approximately 80% domestic Korean market share.
Ownership category
akta.pro rank

OsteoSys industry classification

Industry
Product category
Bone Densitometry and Musculoskeletal Medical Imaging Devices
NAICS
Electromedical and Electrotherapeutic Apparatus Manufacturing (334510)
SIC
Electromedical & Electrotherapeutic Apparatus (3845)
akta.pro industry
PRIMARYHLAHABAA
X-ray & Fluoroscopy Systems
Healthcare & Life Sciences/Medical Devices & Diagnostics/Medical Imaging & Radiology Equipment
SECONDARYHLAKALAM
Pain Management (Spine & Musculoskeletal)

Keywords

  • Bone densitometry equipment
  • DXA body composition
  • Quantitative ultrasound BMD
  • Shock wave therapy devices
  • Preclinical DXA imaging

Where OsteoSys is headquartered

Location

Headquarters

HQ city
Seoul
HQ country
South Korea
HQ region
Asia

Offices2 records

Markets served

OsteoSys business model

Business model
GTM type
B2B
Offering type
Hardware or Manufacturing
Cost components
Personnel, Technology or R&D, Operations, Marketing or Sales, Supply Chain

Revenue model

  1. Medical Device Sales: Sale of bone mineral density diagnostic equipment (DXA systems, QUS devices) and ESWT treatment devices to healthcare providers, hospitals, and research institutions.
  2. Software Solutions: Sale of related software solutions including body composition analysis software, BMD reporting systems, and TBS iNsight integration for enhanced bone health assessment.
  3. Service and Maintenance: Customer service and support including remote support services, domestic service hotline (1551-5099), and overseas service support.

Pricing tiers

ModelBillingPrice
OtherMulti-year contractEnterprise/Institutional Pricing

Go-to-market motion2 records

Distribution channels3 records

Marketing channels4 records

OsteoSys product offering

Product offering

Core offering

OsteoSys manufactures and sells bone mineral density (BMD) diagnostic systems based on Dual Energy X-ray Absorptiometry (DXA) and Quantitative Ultrasound (QUS), body composition analyzers, Extracorporeal Shock Wave Therapy (ESWT) devices for musculoskeletal pain, and preclinical/veterinary DXA imaging cabinets. Its products serve hospitals, clinics, research institutions, universities and government health programs for osteoporosis diagnosis, sarcopenia assessment, body composition analysis and musculoskeletal pain therapy.

Product overview

OsteoSys is a medical device manufacturer specializing in bone health diagnostic equipment and musculoskeletal therapy devices. The product portfolio includes: BMD diagnostic systems using DXA technology (PRIMUS whole-body scanner, EXCELLUS half-body scanner, DEXXUM T series, EXA series) and QUS technology (SONOST series, BeeTLe portable device); NPT-Sonicure for extracorporeal shock wave therapy treating musculoskeletal pain conditions; and iNSiGHT for preclinical/veterinary DXA analysis of lab animals. The company holds approximately 80% domestic Korean market share and exports to over 70 countries worldwide.

Differentiator

Problem solved

Functional benefit

Brands

  • SoniCure: Brand name for OsteoSys's Extracorporeal Shock Wave Therapy (ESWT) technology products.

Products and services

  • PRIMUS Whole-body DXA scanner for bone mineral density and body composition analysis including lean mass, fat mass and bone mass measurements; recognized as new medical technology since 2019 for simultaneous sarcopenia and osteoporosis diagnosis.
  • EXCELLUS Half-body DXA scanner for precise measurement of fat mass, muscle mass and bone mineral density with scientific body composition monitoring.
  • DEXXUM T Table DXA system for bone mineral density assessment at the spine and hip; EU MDR certified.
  • DEXXUM T QUANTUM Advanced table DXA system with quantum technology for enhanced bone density measurements; EU MDR certified.
  • EXA-3000 Peripheral DXA system for bone mineral density measurement at specific skeletal sites such as the forearm or heel; EU MDR certified.
  • EXA-PRESTO Peripheral DXA device for clinical bone density assessment in office or point-of-care settings.
  • SONOST 3000 Portable stand-alone quantitative ultrasound (QUS) bone densitometer with embedded PC, colorful touch screen, built-in thermal printer, temperature compensation and automatic probe positioning; uses SOS and BUA measurements for calcaneal BMD calculation.
  • SONOST-2000 Quantitative ultrasound bone densitometer for calcaneal bone mineral density measurement.
  • BeeTLe Portable wireless QUS bone mineral densitometer with NFC and Bluetooth functions, providing a 5-second calcaneal BMD test controlled via a mobile phone application through one-touch measurement.
  • NPT-Sonicure (SoniCure) Next-generation extracorporeal shock wave therapy (ESWT) device based on digital array control technology with world-first 3D dynamic focusing; provides software-based depth adjustment without gel pad replacement for pain-free musculoskeletal treatment at the skin surface.
  • iNSiGHT Fully shielded preclinical DXA cabinet for in-vivo body composition and BMD analysis in lab animals; uses cone beam HFG and a flat panel detector to complete scans in 25 seconds (10 seconds of X-ray exposure) with 100-micron high-resolution imaging, multiple ROIs and longitudinal study capability without requiring animal sacrifice.

Quantifiable outcome

  • 80% domestic market share in Korea's bone density DXA device market
  • +3 more outcomes

Companies that use OsteoSys

Customer profile

Named customers8 records

Segments3 records

Ideal customer profiles4 records

OsteoSys technology and API

Technology

Technology focussed Yes

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

Integration1 record

Feature5 records

OsteoSys partnerships and signals

Strategic signal

Partnerships

One partnership is on record.

  • Medimaps GroupcoreTechnology or Integration · 14 November 2022Medimaps Group, a Swiss/Global med-tech company specializing in image processing software for bone health, partnered with OsteoSys to integrate TBS iNsight (Trabecular Bone Score) technology into OsteoSys' Primus Whole Body DXA scanner. This partnership enhances osteoporosis fracture risk assessment by combining BMD measurement with bone microarchitecture analysis using AI-powered technology. TBS iNsight has CE 2797 mark, FDA 510(k) clearance, and is cleared in 60+ countries. The integration expands access to Medimaps' technology throughout Southeast Asia, Europe, and South America.

Scale indicators6 records

Recent moves9 records

Expansion highlights5 records

OsteoSys competitors and assessment

Company assessment

Direct peers

  • Hologic: Hologic is the global market leader in DXA bone densitometry (Discovery/Horizon platforms) alongside women's health imaging. It is OsteoSys's most direct competitor in whole-body DXA sales to hospitals and clinics worldwide.
  • DMS Group: DMS Group (France) is a specialist DXA and bone densitometry manufacturer (Stratos, Lexxos) competing head-to-head with OsteoSys's PRIMUS, EXCELLUS and DEXXUM T lines in European and emerging-market tenders.
  • Norland (CooperSurgical): Norland at CooperSurgical is a legacy DXA bone densitometer brand (XR-Series) with overlapping research and clinical customers. It is a direct substitute for OsteoSys's table DXA systems in osteoporosis and body composition research labs.

Broad incumbents

  • Hitachi: Hitachi supplies diagnostic imaging systems including X-ray modalities used in hospitals globally. As a broad incumbent with overlapping imaging channels, it competes with OsteoSys at the hospital capital-equipment procurement level, especially in Asia.
  • GE Healthcare: GE Healthcare sells the Lunar iDXA bone densitometer line as part of a much broader diagnostic imaging portfolio. OsteoSys explicitly positions itself as a top-3 global bone densitometry player 'alongside GE and Hologic,' making GE the anchor incumbent peer.
  • Swissray: Swissray manufactures digital radiography (DR) X-ray systems used in hospitals and clinics. Its DR X-ray capability overlaps with the X-ray based technology stack underlying OsteoSys's DXA and combined DR X-ray/DXA veterinary platform.
  • Philips: Philips Healthcare is a global diagnostic imaging incumbent whose X-ray and women's-health portfolio overlaps with OsteoSys's DXA positioning at large hospital networks and reference centers.

Emerging players

  • BeamMed: BeamMed (Israel) develops quantitative ultrasound (QUS) bone densitometry devices (Sunlight Omnisense). It overlaps directly with OsteoSys's SONOST and BeeTLe QUS product lines in pediatric and point-of-care bone assessment.

Others

  • Medimaps Group: Medimaps Group (Switzerland) provides TBS iNsight, a CE-marked and FDA-cleared trabecular bone score software that OsteoSys integrates into PRIMUS. It is a strategic partner and adjacent ecosystem peer rather than a direct device competitor.

Regional players

  • Furuno Electric: Furuno (Japan) supplies medical imaging and electronic equipment, including diagnostic modalities in the Japanese market. It is a regional peer for OsteoSys's preclinical DXA and bone densitometry exports to Japan (e.g., University of Tokyo).

Market position

Strengths5 records

Weaknesses5 records

Competitive moat5 records

Key risks5 records

Key highlights7 records

Customer concentration

OsteoSys social profiles

Digital presence

OsteoSys compliance and trust

Trust signal

Compliance1 record

OsteoSys financial estimates

Financial estimate

Revenue estimate

Valuation estimate

OsteoSys leadership team

Management profile

Number of profiles

Profiles1 record

OsteoSys funding detail

Funding detail

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

OsteoSys M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about OsteoSys

What does OsteoSys do?

OsteoSys manufactures and sells bone mineral density (BMD) diagnostic systems based on Dual Energy X-ray Absorptiometry (DXA) and Quantitative Ultrasound (QUS), body composition analyzers, Extracorporeal Shock Wave Therapy (ESWT) devices for musculoskeletal pain, and preclinical/veterinary DXA imaging cabinets. Its products serve hospitals, clinics, research institutions, universities and government health programs for osteoporosis diagnosis, sarcopenia assessment, body composition analysis and musculoskeletal pain therapy.

Is OsteoSys a public or private company?

OsteoSys is a public company. It is classified as public and is currently operating.

When was OsteoSys founded?

OsteoSys was founded in 2000. It employs 11 to 50 people.

Where is OsteoSys based?

OsteoSys is headquartered in Seoul, South Korea, in the Asia region.

How does OsteoSys make money?

Three revenue lines are on record. Medical Device Sales are the primary driver. The others are software Solutions and service and Maintenance.

Who are OsteoSys's main competitors?

Direct peers on record are Hologic, DMS Group and Norland (CooperSurgical). Broad incumbents are Hitachi, GE Healthcare, Swissray and Philips. BeamMed is listed as an emerging player. Medimaps Group is listed as an others. Furuno Electric is listed as a regional player.

Does OsteoSys have an API?

No public API is recorded for OsteoSys.

What industry is OsteoSys in?

OsteoSys's product category is Bone Densitometry and Musculoskeletal Medical Imaging Devices. Its primary akta.pro industry code is HLAHABAA, X-ray & Fluoroscopy Systems, with a secondary code of HLAKALAM, Pain Management (Spine & Musculoskeletal). Its NAICS code is 334510 and its SIC code is 3845.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales